Device Trial Radar · NCT05612139
Post-market Observational Study on JTIN Telescopic Nail in Osteogenesis Imperfecta Pediatric Patients
Last checked: Nov 20, 2026Latest source record: Jan 26, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
14
Actual
Start
Aug 27, 2024
Primary completion
Feb 20, 2025
Study completion Feb 20, 2025
Sponsor
- Lead sponsor
- Orthofix s.r.l.Public (OFIX)
- Sponsor type
- Industry
- First posted
- Nov 10, 2022
Design
- Study type
- Observational
- FDA-regulated device
- No
- Who can join
- All sexes, from 18 months, up to 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This study has been planned as part of the Orthofix Srl post-market active surveillance plan for the collection of data on both the clinical performance and the safety profile of the JTIN. The rationale of the proposed study is to update and support the pre-market clinical evaluation of the JTIN with Real World Evidence clinical data in a real-life surgical setting, in order to confirm the benefit/risk ratio of this medical device and to keep the CE mark under Medical Device Regulation (MDR) requirements. One selected site, experienced in the treatment of pediatric patients with OI, where the usage of JTIN is already part of the normal clinical practice, will participate in this study.
Conditions
- Osteogenesis Imperfecta
Interventions
JTIN implantation surgeryDevice
The JTIN is a self-extending intramedullary nail (telescopic rod) designed to provide fixation of femoral and/or tibial fractures, osteotomies, malunions and non-unions. The design of the JTIN includes a female and a male component, which are anchored to the proximal cortex and distal epiphysis through screw-type fixation. These two components slide from each other, allowing for extension of the JTIN as the bone structures remodel and patient growth occurs.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Percentage of Procedures With at Least One Serious/Not Serious Adverse Event Certainly or Possibly Related to JTINTime frame: 1 year
Locations
1 site in 1 country. Site status is shown where the registry gives one.
Necker-Enfants Malades Hospital
Paris, Île-de-France Region, France
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.